Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RIECKMANN P")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 74

  • Page / 3
Export

Selection :

  • and

ENTGASUNG VON WASSER DURCH KAVITATION. = DEGAZAGE DE L'EAU PAR CAVITATIONRIECKMANN P.1975; ACUSTICA; ALLEM.; DA. 1975; VOL. 33; NO 3; PP. 192-197; ABS. ANGL. FR.; BIBL. 10 REF.Article

EROSION AN METALOBERFLAECHEN DURCH ULTRASCHALLKAVITATION = EROSION DES SURFACES METALLIQUES PAR CAVITATION ULTRASONORERIECKMANN P.1978; ACUSTICA; DEU; DA. 1978; VOL. 41; NO 5; PP. 336-337Article

DIE OBERFLAECHEN DER SCHALLGEBER UND DIE ULTRASCHALLKAVITATION. = LES SURFACES EXTERIEURES DES EMETTEURS ACOUSTIQUES ET LA CAVITATION ULTRASONORERIECKMANN P.1977; ACUSTICA; ALLEM.; DA. 1977; VOL. 37; NO 3; PP. 183-189; ABS. ANGL. FR.; BIBL. 9 REF.Article

Managing the adverse effects of interferon-β therapy in multiple sclerosisBAYAS, A; RIECKMANN, P.Drug safety. 2000, Vol 22, Num 2, pp 149-159, issn 0114-5916Article

Emerging oral therapies for multiple sclerosisCOHEN, B. A; RIECKMANN, P.International journal of clinical practice (Esher). 2007, Vol 61, Num 11, pp 1922-1930, issn 1368-5031, 9 p.Article

Neuritis nervi optici: Erster Hinweis auf eine Multiple Sklerose? Aktuelle diagnostische und therapeutische Strategien = Optic neuritisKIEFER, G; RIECKMANN, P.Der Ophthalmologe (Berlin. Print). 2001, Vol 98, Num 3, pp 310-319, issn 0941-293XArticle

Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen bloodKRUSE, N; PETTE, M; TOYKA, K et al.Journal of immunological methods. 1997, Vol 210, Num 2, pp 195-203, issn 0022-1759Article

Acute inflammatory CNS disease after MDMA ('ecstasy')BITSCH, A; THIEL, A; RIECKMANN, P et al.European neurology. 1996, Vol 36, Num 5, pp 328-329, issn 0014-3022Article

Okadaic acid is a potent inducer of AP-1, NF-κB, and tumor necrosis factor-α in human B lymphocytesRIECKMANN, P; THEVENIN, C; KEHRL, J. H et al.Biochemical and biophysical research communications (Print). 1992, Vol 187, Num 1, pp 51-57, issn 0006-291XArticle

Symptomatic treatment of multiple sclerosis : Multiple sclerosis therapy consensus group (MSTCG) of the German multiple sclerosis societyHENZE, T; RIECKMANN, P; TOYKA, K. V et al.European neurology. 2006, Vol 56, Num 2, pp 78-105, issn 0014-3022, 28 p.Article

The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-β1b treatment in patients with multiple sclerosisRIECKMANN, P; WEBER, F; GÜNTHER, A et al.Neurology. 1996, Vol 47, Num 2, issn 0028-3878, p. 604Article

Regulation of JC virus expression in B lymphocytesRIECKMANN, P; MICHEL, U; KEHRL, J. H et al.Journal of virology. 1994, Vol 68, Num 1, pp 217-222, issn 0022-538XArticle

Plasma exchange for severe optic neuritis. Treatment of 10 patientsRUPRECHT, K; KLINKER, E; DINTELMANN, T et al.Neurology. 2004, Vol 63, Num 6, pp 1081-1083, issn 0028-3878, 3 p.Article

Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNAKEHRL, J. H; THEVENIN, C; RIECKMANN, P et al.The Journal of immunology (1950). 1991, Vol 146, Num 11, pp 4016-4023, issn 0022-1767, 8 p.Article

Activated B lymphocytes for human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1RIECKMANN, P; POLI, G; KEHRL, J. H et al.The Journal of experimental medicine. 1991, Vol 173, Num 1, pp 1-5, issn 0022-1007, 5 p.Article

Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cellsKRUSE, N; MORIABADI, N. F; TOYKA, K. V et al.Journal of immunological methods. 2001, Vol 247, Num 1-2, pp 131-139, issn 0022-1759Article

Telencephalin as an indicator for temporal-lobe dysfunctionRIECKMANN, P; TURNER, T; KILGANNON, P et al.Lancet (British edition). 1998, Vol 352, Num 9125, pp 370-371, issn 0140-6736Article

Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosisBOGUMIL, T; RIECKMANN, P; KUBUSCHOK, B et al.Neuroscience letters. 1998, Vol 247, Num 2-3, pp 195-197, issn 0304-3940Article

Escalating immunotherapy of multiple sclerosisRIECKMANN, P; TOYKA, K. V.European neurology. 1999, Vol 42, Num 3, pp 121-127, issn 0014-3022Article

Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosisKAHL, K. G; KRUSE, N; TOYKA, K. V et al.Journal of the neurological sciences. 2002, Vol 200, Num 1-2, pp 53-55, issn 0022-510XArticle

Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosisCURSIEFEN, S; FLACHENECKER, P; TOYKA, K. V et al.European neurology. 2000, Vol 43, Num 3, pp 186-187, issn 0014-3022Article

Effect of interferon β on human myelin basic protein-specific T-cell lines : Comparison of IFNβ-1a and IFNβ-1bWEBER, F; JANOVSKAJA, J; POLAK, T et al.Neurology. 1999, Vol 52, Num 5, pp 1069-1071, issn 0028-3878Article

Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosisRIECKMANN, P; ALTENHOFEN, B; RIEGEL, A et al.Annals of neurology. 1997, Vol 41, Num 3, pp 326-333, issn 0364-5134Article

Expression of tumor necrosis factor-α and interferon-γ mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosisKAHL, K. G; KRUSE, N; FALLER, H et al.Psychoneuroendocrinology. 2002, Vol 27, Num 6, pp 671-681, issn 0306-4530Article

Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1KALLMANN, B. A; HUMMEL, V; LINDENLAUB, T et al.Brain. 2000, Vol 123, pp 687-697, issn 0006-8950, 4Article

  • Page / 3